Sinopec Shanghai Petrochemical Past Earnings Performance
Past criteria checks 0/6
Sinopec Shanghai Petrochemical's earnings have been declining at an average annual rate of -47.2%, while the Chemicals industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 0.05% per year.
Key information
-47.2%
Earnings growth rate
-46.9%
EPS growth rate
Chemicals Industry Growth | 10.2% |
Revenue growth rate | 0.05% |
Return on equity | -2.6% |
Net Margin | -0.7% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Sinopec Shanghai Petrochemical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 89,150 | -652 | 1,711 | 269 |
30 Jun 24 | 91,609 | -390 | 1,888 | 216 |
31 Mar 24 | 92,318 | -1,159 | 1,872 | 191 |
31 Dec 23 | 93,014 | -1,406 | 1,951 | 187 |
30 Sep 23 | 94,599 | -1,589 | 1,633 | 160 |
30 Jun 23 | 81,555 | -3,424 | 1,737 | 162 |
31 Mar 23 | 78,490 | -3,249 | 1,698 | 149 |
31 Dec 22 | 82,518 | -2,872 | 1,808 | 131 |
30 Sep 22 | 85,196 | -1,967 | 857 | 102 |
30 Jun 22 | 98,044 | 320 | 2,145 | 103 |
31 Mar 22 | 94,907 | 1,041 | 1,936 | 94 |
31 Dec 21 | 89,280 | 2,001 | 2,206 | 94 |
30 Sep 21 | 81,614 | 3,235 | 2,469 | 127 |
30 Jun 21 | 76,178 | 3,588 | 1,817 | 91 |
31 Mar 21 | 77,158 | 3,004 | 2,070 | 117 |
31 Dec 20 | 74,705 | 628 | 1,879 | 111 |
30 Sep 20 | 79,930 | -101 | 1,924 | 122 |
30 Jun 20 | 84,017 | -640 | 2,029 | 119 |
31 Mar 20 | 93,136 | 401 | 1,833 | 92 |
31 Dec 19 | 100,346 | 2,214 | 1,943 | 93 |
30 Sep 19 | 102,314 | 2,289 | 1,711 | 67 |
30 Jun 19 | 107,570 | 2,890 | 1,301 | 45 |
31 Mar 19 | 107,142 | 4,116 | 1,929 | 44 |
31 Dec 18 | 107,765 | 5,277 | 1,888 | 37 |
30 Sep 18 | 104,676 | 6,700 | 1,988 | 37 |
30 Jun 18 | 101,094 | 7,090 | 2,681 | 39 |
31 Mar 18 | 95,201 | 5,984 | 1,786 | 37 |
31 Dec 17 | 92,014 | 6,142 | 1,888 | 37 |
30 Sep 17 | 91,467 | 5,927 | 2,058 | 0 |
30 Jun 17 | 84,008 | 5,434 | 1,716 | 11 |
31 Mar 17 | 83,901 | 6,739 | 1,979 | 0 |
31 Dec 16 | 77,894 | 5,956 | 1,955 | 0 |
30 Sep 16 | 73,830 | 5,130 | 2,152 | 0 |
30 Jun 16 | 75,644 | 4,611 | 2,092 | 0 |
31 Mar 16 | 77,738 | 4,339 | 2,179 | 0 |
31 Dec 15 | 80,803 | 3,246 | 2,105 | 0 |
30 Sep 15 | 87,022 | 1,681 | 2,154 | 0 |
30 Jun 15 | 92,961 | 1,180 | 2,110 | 0 |
31 Mar 15 | 97,700 | -591 | 2,196 | 0 |
31 Dec 14 | 102,183 | -716 | 2,011 | 0 |
30 Sep 14 | 105,902 | 847 | 2,063 | 0 |
30 Jun 14 | 109,803 | 1,401 | 2,157 | 0 |
31 Mar 14 | 110,796 | 1,758 | 1,956 | 0 |
31 Dec 13 | 115,540 | 2,004 | 2,182 | 0 |
Quality Earnings: 338 is currently unprofitable.
Growing Profit Margin: 338 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 338 is unprofitable, and losses have increased over the past 5 years at a rate of 47.2% per year.
Accelerating Growth: Unable to compare 338's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 338 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-29.6%).
Return on Equity
High ROE: 338 has a negative Return on Equity (-2.63%), as it is currently unprofitable.